Global cDNA Reverse Transcription Kit Market, By Application (Florescent Probe Application, Library Construction, One-Step RT-PCR, RACE, Small RNA cloning, Standard RT-PCR, Subtractive Hybridization, and Two-step RT-PCR), By End User (Biopharmaceutical Companies, Biotechnology Companies, and Academic & Research Institutes), and opportunities and forecast 2020-2027
cDNA Reverse Transcription Kit Market Overview
The global cDNA Reverse Transcription Kit market is expected to grow at a moderate rate during the forecast period. The rise in R&D spending and activities for biotechnological applications, upsurge in biotechnology companies worldwide, and upsurge in PCR applications, are boosting the growth of the global cDNA Reverse Transcription Kit market. Furthermore, a rise in demand for easy and ready-to-use kit-based DNA and RNA products would help the cDNA reverse transcription kit market grow during the forecast period.
Moreover, governments in many countries are supporting and taking initiatives for the adoption of transcription kits for the synthesis of cDNA and PCR amplification is the important factor expected to boost the growth of the cDNA Reverse Transcription Kit market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.
On the other hand, the presence of less-skilled professionals and the higher cost of equipment that is associated with these kits including PCR is likely to hamper the global cDNA Reverse Transcription Kit market during the forecast period.
Covid-19 Impact on cDNA Reverse Transcription Kit Market:
In addition, the current cDNA Reverse Transcription Kit Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the cDNA Reverse Transcription Kit Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
According to the application, the market is segmented into fluorescent probe application, library construction, One-Step RT-PCR, RACE, small RNA cloning, standard RT-PCR, subtractive hybridization, and Two-step RT-PCR. Among these libraries, construction holds a significantly large share of the market mainly because of the growth in demand for cDNA reverse transcription kits for library construction and especially due to the advantages of library construction for helping in organizing the DNA extraction.
Based on application, the biopharmaceutical companies segment is expected to grow at the highest rate in the coming years. In addition, the advantages of the cDNA reverse transcription such as aiding in can do quantitative as well as qualitative analysis, smaller amount of sample gene expression studies and simplicity, ease to use, rapidness, the cost-effectiveness of the cDNA transcription for pharmaceutical drugs to be manufactured is boosting the demand for cDNA Reverse Transcription Kit globally.
Market Analysis, Insights and Forecast – By Application
· Fluorescent Probe Application · Library Construction · One-Step RT-PCR · RACE · Small RNA cloning · Standard RT-PCR · Subtractive Hybridization · Two-step RT-PCR
Market Analysis, Insights, and Forecast – By End-user
Region-wise, North America dominated the global cDNA Reverse Transcription Kit market and is expected to continue its dominance during the forecast period. Factors such as the high health care expenditure propel the growth of the market in North America. Furthermore, a surge in R&D in the North American region would propel the growth of the industry in the coming years. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in healthcare sectors, and growing adoption of R&D activities for transcription kits are expected to escalate the growth of the cDNA Reverse Transcription Kit market in the Asia Pacific region.
cDNA Reverse Transcription Kit Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Some key developments and strategies adopted by manufacturers in the cDNA Reverse Transcription Kit are highlighted below.
· In March 2020, Bio-Rad Laboratories, Inc., which is a global leader of life science research and clinical diagnostic products, announced the launch of the Reliance Select cDNA Synthesis Kit to help researchers efficiently convert RNA to DNA by reverse transcription.